WO2007115123A3 - Mineralized three-dimensional bone constructs - Google Patents

Mineralized three-dimensional bone constructs Download PDF

Info

Publication number
WO2007115123A3
WO2007115123A3 PCT/US2007/065542 US2007065542W WO2007115123A3 WO 2007115123 A3 WO2007115123 A3 WO 2007115123A3 US 2007065542 W US2007065542 W US 2007065542W WO 2007115123 A3 WO2007115123 A3 WO 2007115123A3
Authority
WO
WIPO (PCT)
Prior art keywords
bone
constructs
bone constructs
mineralized
gravity vector
Prior art date
Application number
PCT/US2007/065542
Other languages
French (fr)
Other versions
WO2007115123A2 (en
Inventor
Mark Clarke
Alamelu Sundaresan
Neal Pellis
Original Assignee
Mark Clarke
Alamelu Sundaresan
Neal Pellis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mark Clarke, Alamelu Sundaresan, Neal Pellis filed Critical Mark Clarke
Priority to AT07759733T priority Critical patent/ATE531792T1/en
Priority to ES07759733T priority patent/ES2376222T3/en
Priority to EP07759733A priority patent/EP2013730B1/en
Publication of WO2007115123A2 publication Critical patent/WO2007115123A2/en
Publication of WO2007115123A3 publication Critical patent/WO2007115123A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3847—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2525/00—Culture process characterised by gravity, e.g. microgravity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present disclosure provides ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The bone constructs of the disclosure have utility in physiological studies of bone formation and bone function, in drug discovery, and in orthopedics.
PCT/US2007/065542 2006-03-30 2007-03-29 Mineralized three-dimensional bone constructs WO2007115123A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT07759733T ATE531792T1 (en) 2006-03-30 2007-03-29 THREE-DIMENSIONAL MINERALIZED BONE CONSTRUCTS
ES07759733T ES2376222T3 (en) 2006-03-30 2007-03-29 MINERALIZED THREE-DIMENSIONAL BONE CONSTRUCTIONS.
EP07759733A EP2013730B1 (en) 2006-03-30 2007-03-29 Mineralized three-dimensional bone constructs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78743106P 2006-03-30 2006-03-30
US60/787,431 2006-03-30

Publications (2)

Publication Number Publication Date
WO2007115123A2 WO2007115123A2 (en) 2007-10-11
WO2007115123A3 true WO2007115123A3 (en) 2009-04-09

Family

ID=38564225

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/065542 WO2007115123A2 (en) 2006-03-30 2007-03-29 Mineralized three-dimensional bone constructs

Country Status (5)

Country Link
US (3) US8076136B2 (en)
EP (1) EP2013730B1 (en)
AT (1) ATE531792T1 (en)
ES (1) ES2376222T3 (en)
WO (1) WO2007115123A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007115123A2 (en) * 2006-03-30 2007-10-11 Mark Clarke Mineralized three-dimensional bone constructs
WO2009064956A1 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc A novel tissue culture platform for screening of potential bone remodeling agents
WO2009064957A1 (en) 2007-11-14 2009-05-22 Osteosphere, Llc Development of a human colloidal bone graft material
WO2009064917A2 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc Generation of an hla-negative osteogenic precursor cell line
US20110082549A1 (en) * 2008-02-01 2011-04-07 Osteosphere, Llc Mineralized three-dimensional bone constructs formed from osteoblasts
ES2775977T3 (en) 2008-04-10 2020-07-28 Bonus Therapeutics Ltd Prosthetic bone-like implants
US8278101B2 (en) * 2009-12-07 2012-10-02 Synthecon, Inc. Stem cell bioprocessing and cell expansion
IL204116A (en) * 2010-02-23 2013-10-31 Sheltagen Medical Ltd Three-dimensional bone implant and method for producing same
US9110282B2 (en) * 2011-03-30 2015-08-18 The Regents Of The University Of California Nanometer-scale optical imaging by the modulation tracking (MT) method
WO2015155777A1 (en) 2014-04-10 2015-10-15 Bonus Therapeutics Ltd. Bone repair compositions
US20200308524A1 (en) * 2017-10-10 2020-10-01 Temple University-of The Commonwealth SAystem of Higher Education Device and Method for Enhanced Air Bubble Removal from Rotary Bioreactor Cell Cultures and Culture Chambers
KR102648746B1 (en) * 2020-05-13 2024-03-18 한국기초과학지원연구원 Bone tissue mimetics and method for preparing the same
WO2023085837A1 (en) * 2021-11-11 2023-05-19 한국기초과학지원연구원 Method and device for screening for osteoporosis drug by using bone tissue mimetic image analysis
KR102531759B1 (en) * 2021-11-11 2023-05-12 한국기초과학지원연구원 Method and Apparatus for Screening Osteoporosis Drug Based on Image Analysis of Bone Tissue Mimetics

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012512A1 (en) * 2003-08-01 2005-02-10 Norimasa Nakamura Scaffold-free self-organized 3d synthetic tissue

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026650A (en) 1988-06-30 1991-06-25 The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration Horizontally rotated cell culture system with a coaxial tubular oxygenator
US5496722A (en) 1988-06-30 1996-03-05 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method for producing non-neoplastic, three dimensional, mammalian tissue and cell aggregates under microgravity culture conditions and the products produced therefrom
US5962324A (en) 1988-06-30 1999-10-05 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Adminstration Three dimensional optic tissue culture and process
US5155034A (en) 1988-06-30 1992-10-13 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Three-dimensional cell to tissue assembly process
US5851816A (en) 1988-06-30 1998-12-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Cultured high-fidelity three-dimensional human urogenital tract carcinomas and process
US5308764A (en) 1988-06-30 1994-05-03 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Multi-cellular, three-dimensional living mammalian tissue
US4988623A (en) 1988-06-30 1991-01-29 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Rotating bio-reactor cell culture apparatus
US5153151A (en) 1991-05-06 1992-10-06 Corning Incorporated High index fluorine-free phosphate glasses
US5858783A (en) 1993-05-25 1999-01-12 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Production of normal mammalian organ culture using a medium containing mem-alpha, leibovitz L-15, glucose galactose fructose
US5437998A (en) 1993-09-09 1995-08-01 Synthecon, Inc. Gas permeable bioreactor and method of use
US5856112A (en) 1994-06-16 1999-01-05 Urocor, Inc. Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof
US5972703A (en) * 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US5827729A (en) 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
US6001642A (en) 1998-06-29 1999-12-14 Wyle Laboratories, Inc. Life Sciences Bioreactor and cell culturing processes using the bioreactor
KR100563476B1 (en) 1998-07-03 2006-03-27 이진용 Bone regeneration material
US6107081A (en) 1999-02-05 2000-08-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Uni-directional cell stretching device
DE19932439C2 (en) 1999-07-12 2002-06-13 Sefar Ag Rueschlikon bioreactor
US6811776B2 (en) 2000-12-27 2004-11-02 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
KR100371559B1 (en) 2000-04-03 2003-02-06 주식회사 경원메디칼 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
US6773713B2 (en) 2001-02-23 2004-08-10 University Of Massachusetts Injection molding of living tissues
FR2821853B1 (en) 2001-03-09 2003-05-16 Natural Implant Sa BIOREACTOR FOR THIN FILM CULTIVE TISSUE AND USES
US6998264B2 (en) 2002-11-19 2006-02-14 Huntington Medical Research Institutes Replication of biological tissue
US7291345B2 (en) * 2002-12-12 2007-11-06 Osteotech, Inc. Formable and settable polymer bone composite and method of production thereof
US7494811B2 (en) 2003-05-01 2009-02-24 Lifenet Health In vitro growth of tissues suitable to the formation of bone and bone forming tissue formed thereby
US7302801B2 (en) 2004-04-19 2007-12-04 Hamilton Sundstrand Corporation Lean-staged pyrospin combustor
WO2007115123A2 (en) * 2006-03-30 2007-10-11 Mark Clarke Mineralized three-dimensional bone constructs
WO2009064957A1 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc Development of a human colloidal bone graft material

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012512A1 (en) * 2003-08-01 2005-02-10 Norimasa Nakamura Scaffold-free self-organized 3d synthetic tissue

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FACER, S.R. ET AL.: "Rotary culture enhances pre-osteoblast aggregation and mineralization.", J. DENT. RES., vol. 84, no. 6, 2005, pages 542 - 547, XP008131896 *
GLANTSCHNIG ET AL.: "M-CSF, TNFa and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.", CELL DEATH AND DIFFERENTIATION., vol. 10, 2003, pages 1165 - 1177, XP008130560 *
MARLOVITS ET AL.: "Chondrogenesis of Aged Human Articular Cartilage in a Scaffold-Free Bioreactor.", TISSUE ENGINEERING, vol. 9, no. 6, 2003, pages 1215 - 1226, XP002534525 *
NAKAGAWA ET AL.: "Osteoclastogenesis on Tissue-Engineered Bone. pg 93-100", TISSUE ENGINEERING, vol. 10, no. 1/2, 2004, XP008131897 *
YU ET AL.: "Bioreactor-based bone tissue engineering: the influence of dynamic flow on osteoblast phenotypic expression and matrix mineralization.", PNAS, vol. 101, no. 31, 2004, pages 11203 - 11208, XP008130559 *

Also Published As

Publication number Publication date
WO2007115123A2 (en) 2007-10-11
US20120058557A1 (en) 2012-03-08
ATE531792T1 (en) 2011-11-15
US8076136B2 (en) 2011-12-13
US20100227358A1 (en) 2010-09-09
ES2376222T3 (en) 2012-03-12
EP2013730A2 (en) 2009-01-14
US8557576B2 (en) 2013-10-15
US20090061479A1 (en) 2009-03-05
EP2013730A4 (en) 2010-05-26
EP2013730B1 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
WO2007115123A3 (en) Mineralized three-dimensional bone constructs
WO2007117765A3 (en) Ex vivo generated tissue system
WO2012142569A3 (en) Decellularized extracellular matrix
WO2007120302A3 (en) Liquid crystalline substrates for culturing cells
WO2009002456A3 (en) Methods and compositions relating to progenitor cells
MX2010002825A (en) Biological oils and production and uses thereof.
WO2013005110A3 (en) Synthetic scaffolds and organ and tissue transplantation
EP2418271A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
WO2007030811A3 (en) Tissue engineering methods and compositions
EP3130667A3 (en) Methods of preparing mesenchymal stem cells, compositions and kit thereof
WO2009002772A3 (en) Bioreactor
EP3369807A3 (en) Enhanced production of fatty acid derivatives
WO2007112084A3 (en) Method to modulate hematopoietic stem cell growth
MX2013013028A (en) METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF.
MX2012000455A (en) Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions.
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
EP3623465A3 (en) Production of fatty acids and derivatives thereof
SG171577A1 (en) Methods for producing yeast-based vaccines
WO2012024390A3 (en) Biohybrid composite scaffold
WO2011097506A3 (en) Methods of using water-soluble inorganic compounds for implants
MX2011008373A (en) Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies.
MY156887A (en) Block coordination copolymers
MX2011011182A (en) Modulators of 5-ht receptors and methods of use thereof.
WO2008058233A3 (en) In vivo bioreactors and methods of making and using same
WO2009134368A3 (en) Methods of producing bacterial alginates

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07759733

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007759733

Country of ref document: EP